Skin wound healing in diabetic β6 integrin-deficient mice

APMIS

Volumn 118, Issue 10, 2010, Pages 753-764

  Jacobsen, Jasper N ^a,b   Steffensen, BjØrn ^c   HÄkkinen, Lari ^a   Krogfelt, Karen A ^b   Larjava, Hannu S ^a  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^b STATENS SERUM INSTITUT   (Denmark)

^c UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO   (United States)

Author keywords

advanced glycated endproducts; diabetes mellitus; fibronectin; integrins; Wound healing

Indexed keywords

ADVANCED GLYCATION END PRODUCT; ALPHAVBETA6 INTEGRIN; BETA1 INTEGRIN; BETA6 INTEGRIN; FIBRONECTIN; MATRIX PROTEIN; METHYLGLYOXAL; BETA INTEGRIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL INTERACTION; CONTROLLED STUDY; DIABETIC PATIENT; EPITHELIZATION; EXTRACELLULAR MATRIX; KERATINOCYTE; KNOCKOUT MOUSE; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN GLYCOSYLATION; PROTEIN INTERACTION; SKIN EPITHELIUM; SKIN INJURY; STREPTOZOCIN DIABETES; WILD TYPE; WOUND HEALING; ANIMAL; EXPERIMENTAL DIABETES MELLITUS; IMMUNOHISTOCHEMISTRY; IMMUNOLOGY; METABOLISM; PATHOLOGY;

ANIMALS; DIABETES MELLITUS, EXPERIMENTAL; FIBRONECTINS; GLYCOSYLATION END PRODUCTS, ADVANCED; IMMUNOHISTOCHEMISTRY; INTEGRIN BETA CHAINS; MALE; MICE; MICE, KNOCKOUT; PYRUVALDEHYDE; WOUND HEALING;

EID: 77956938338     PISSN: 09034641     EISSN: 16000463     Source Type: Journal    
DOI: 10.1111/j.1600-0463.2010.02654.x     Document Type: Article

References (55)

1. Wild S, Roglic G, Green A, Sicree R, King H. Global prevalence of diabetes: estimates for the year 2000 and projections for 2030. Diabetes Care 2004 27 : 1047 53.
2. Goren I, Muller E, Pfeilschifter J, Frank S. Severely impaired insulin signaling in chronic wounds of diabetic obob mice: a potential role of tumor necrosis factor-alpha. Am J Pathol 2006 168 : 765 77.
3. Galkowska H, Wojewodzka U, Olszewski WL. Chemokines, cytokines, and growth factors in keratinocytes and dermal endothelial cells in the margin of chronic diabetic foot ulcers. Wound Repair Regen 2006 14 : 558 65.
4. Falanga V. Wound healing and its impairment in the diabetic foot. Lancet 2005 366 : 1736 43.
5. Galiano RD, Tepper OM, Pelo CR, Bhatt KA, Callaghan M, Bastidas N, et al. Topical vascular endothelial growth factor accelerates diabetic wound healing through increased angiogenesis and by mobilizing and recruiting bone marrow-derived cells. Am J Pathol 2004 164 : 1935 47.
6. Maruyama K, Asai J, Ii M, Thorne T, Losordo DW, D'Amore PA. Decreased macrophage number and activation lead to reduced lymphatic vessel formation and contribute to impaired diabetic wound healing. Am J Pathol 2007 170 : 1178 91.
7. Gibran NS, Jang YC, Isik FF, Greenhalgh DG, Muffley LA, Underwood RA, et al. Diminished neuropeptide levels contribute to the impaired cutaneous healing response associated with diabetes mellitus. J Surg Res 2002 108 : 122 8.
8. Lobmann R, Ambrosch A, Schultz G, Waldmann K, Schiweck S, Lehnert H. Expression of matrix-metalloproteinases and their inhibitors in the wounds of diabetic and non-diabetic patients. Diabetologia 2002 45 : 1011 6.
9. Murillo J, Wang Y, Xu X, Klebe RJ, Chen Z, Zardeneta G, et al. Advanced glycation of type I collagen and fibronectin modifies periodontal cell behavior. J Periodontol 2008 79 : 2190 9.
10. Stupack DG. Integrins as a distinct subtype of dependence receptors. Cell Death Differ 2005 12 : 1021 30.
11. De Arcangelis A, Georges-Labouesse E. Integrin and ECM functions: roles in vertebrate development. Trends Genet 2000 16 : 389 95.
12. Hynes RO. Integrins: bidirectional, allosteric signaling machines. Cell 2002 110 : 673 87.
13. Larjava H, Salo T, Haapasalmi K, Kramer RH, Heino J. Expression of integrins and basement membrane components by wound keratinocytes. J Clin Invest 1993 92 : 1425 35.
14. Santoro MM, Gaudino G. Cellular and molecular facets of keratinocyte reepithelization during wound healing. Exp Cell Res 2005 304 : 274 86.
15. Clark EA, Brugge JS. Integrins and signal transduction pathways: the road taken. Science 1995 268 : 233 9.
16. Lu M, Munger JS, Steadele M, Busald C, Tellier M, Schnapp LM. Integrin alpha8beta1 mediates adhesion to LAP-TGFbeta1. J Cell Sci 2002 115 : 4641 8.
17. Munger JS, Huang X, Kawakatsu H, Griffiths MJ, Dalton SL, Wu J, et al. The integrin alpha v beta 6 binds and activates latent TGF beta 1: a mechanism for regulating pulmonary inflammation and fibrosis. Cell 1999 96 : 319 28.
18. Busk M, Pytela R, Sheppard D. Characterization of the integrin alpha v beta 6 as a fibronectin-binding protein. J Biol Chem 1992 267 : 5790 6.
19. Koivisto L, Larjava K, Hakkinen L, Uitto VJ, Heino J, Larjava H. Different integrins mediate cell spreading, haptotaxis and lateral migration of HaCaT keratinocytes on fibronectin. Cell Adhes Commun 1999 7 : 245 57.
20. Annes JP, Munger JS, Rifkin DB. Making sense of latent TGFbeta activation. J Cell Sci 2003 116 : 217 24.
21. Annes JP, Chen Y, Munger JS, Rifkin DB. Integrin alphaVbeta6-mediated activation of latent TGF-beta requires the latent TGF-beta binding protein-1. J Cell Biol 2004 165 : 723 34.
22. Aluwihare P, Mu Z, Zhao Z, Yu D, Weinreb PH, Horan GS, et al. Mice that lack activity of alphavbeta6- and alphavbeta8-integrins reproduce the abnormalities of Tgfb1- and Tgfb3-null mice. J Cell Sci 2009 122 : 227 32.
23. Hakkinen L, Koivisto L, Gardner H, Saarialho-Kere U, Carroll JM, Lakso M, et al. Increased expression of beta6-integrin in skin leads to spontaneous development of chronic wounds. Am J Pathol 2004 164 : 229 42.
24. Huang XZ, Wu JF, Cass D, Erle DJ, Corry D, Young SG, et al. Inactivation of the integrin beta 6 subunit gene reveals a role of epithelial integrins in regulating inflammation in the lung and skin. J Cell Biol 1996 133 : 921 8.
25. AlDahlawi S, Eslami A, Hakkinen L, Larjava HS. The alphavbeta6 integrin plays a role in compromised epidermal wound healing. Wound Repair Regen 2006 14 : 289 97.
26. Mi Q, Riviere B, Clermont G, Steed DL, Vodovotz Y. Agent-based model of inflammation and wound healing: insights into diabetic foot ulcer pathology and the role of transforming growth factor-beta1. Wound Repair Regen 2007 15 : 671 82.
27. Michaels J, Churgin SS, Blechman KM, Greives MR, Aarabi S, Galiano RD, et al. dbdb mice exhibit severe wound-healing impairments compared with other murine diabetic strains in a silicone-splinted excisional wound model. Wound Repair Regen 2007 15 : 665 70.
28. Qiu Z, Kwon AH, Kamiyama Y. Effects of plasma fibronectin on the healing of full-thickness skin wounds in streptozotocin-induced diabetic rats. J Surg Res 2007 138 : 64 70. (Pubitemid 46227451)
29. Greenhalgh DG, Sprugel KH, Murray MJ, Ross R. PDGF and FGF stimulate wound healing in the genetically diabetic mouse. Am J Pathol 1990 136 : 1235 46.
30. Schmidt R., Wirtala J. Modification of Movat pentachrome stain with improved reliability of elastin staining. J Histotechnol 1996 19 : 325 7.
31. Engvall E, Ruoslahti E. Binding of soluble form of fibroblast surface protein, fibronectin, to collagen. Int J Cancer 1977 20 : 1 5.
32. Pal S, Chen Z, Xu X, Mikhailova M, Steffensen B. Co-purified gelatinases alter the stability and biological activities of human plasma fibronectin. J Periodont Res 2010 45 : 292 5.
33. Overall CM, Limeback H. Identification and characterization of enamel proteinases isolated from developing enamel. Amelogeninolytic serine proteinases are associated with enamel maturation in pig. Biochem J 1988 256 : 965 72.
34. Steffensen B, Wallon UM, Overall CM. Extracellular matrix binding properties of recombinant fibronectin type II-like modules of human 72-kDa gelatinasetype IV collagenase. High affinity binding to native type I collagen but not native type IV collagen. J Biol Chem 1995 270 : 11555 66.
35. Shamsi FA, Partal A, Sady C, Glomb MA, Nagaraj RH. Immunological evidence for methylglyoxal-derived modifications in vivo. Determination of antigenic epitopes. J Biol Chem 1998 273 : 6928 36.
36. Stanley CM, Wang Y, Pal S, Klebe RJ, Harkless LB, Xu X, et al. Fibronectin fragmentation is a feature of periodontal disease sites and diabetic foot and leg wounds and modifies cell behavior. J Periodontol 2008 79 : 861 75.
37. Akiyama SK, Yamada SS, Chen WT, Yamada KM. Analysis of fibronectin receptor function with monoclonal antibodies: roles in cell adhesion, migration, matrix assembly, and cytoskeletal organization. J Cell Biol 1989 109 : 863 75.
38. Huang X, Wu J, Spong S, Sheppard D. The integrin alphavbeta6 is critical for keratinocyte migration on both its known ligand, fibronectin, and on vitronectin. J Cell Sci 1998 111 (Pt 15 2189 95.
39. Rossini AA, Like AA, Chick WL, Appel MC, Cahill GF Jr. Studies of streptozotocin-induced insulitis and diabetes. Proc Natl Acad Sci USA 1977 74 : 2485 9.
40. Xie X, Li S, Liu S, Lu Y, Shen P, Ji J. Proteomic analysis of mouse islets after multiple low-dose streptozotocin injection. Biochim Biophys Acta 2008 1784 : 276 84.
41. Like AA, Rossini AA. Streptozotocin-induced pancreatic insulitis: new model of diabetes mellitus. Science 1976 193 : 415 7.
42. Riley WJ, McConnell TJ, Maclaren NK, McLaughlin JV, Taylor G. The diabetogenic effects of streptozotocin in mice are prolonged and inversely related to age. Diabetes 1981 30 : 718 23.
43. Rayat GR, Rajotte RV, Lyon JG, Dufour JM, Hacquoil BV, Korbutt GS. Immunization with streptozotocin-treated NOD mouse islets inhibits the onset of autoimmune diabetes in NOD mice. J Autoimmun 2003 21 : 11 5.
44. Coleman DL. Obese and diabetes: two mutant genes causing diabetes-obesity syndromes in mice. Diabetologia 1978 14 : 141 8.
45. Coleman DL. Diabetes-obesity syndromes in mice. Diabetes 1982 31 : 1 6.
46. Galiano RD, Michaels J, Dobryansky M, Levine JP, Gurtner GC. Quantitative and reproducible murine model of excisional wound healing. Wound Repair Regen 2004 12 : 485 92.
47. Brownlee M. Biochemistry and molecular cell biology of diabetic complications. Nature 2001 414 : 813 20.
48. Xie Y, Gao K, Hakkinen L, Larjava HS. Mice lacking beta6 integrin in skin show accelerated wound repair in dexamethasone impaired wound healing model. Wound Repair Regen 2009 17 : 326 39.
49. Beer HD, Fassler R, Werner S. Glucocorticoid-regulated gene expression during cutaneous wound repair. Vitam Horm 2000 59 : 217 39.
50. Peppa M, Stavroulakis P, Raptis SA. Advanced glycoxidation products and impaired diabetic wound healing. Wound Repair Regen 2009 17 : 461 72.
51. Ahmed N, Argirov OK, Minhas HS, Cordeiro CA, Thornalley PJ. Assay of advanced glycation endproducts (AGEs): surveying AGEs by chromatographic assay with derivatization by 6-aminoquinolyl-N-hydroxysuccinimidyl-carbamate and application to Nepsilon-carboxymethyl-lysine- and Nepsilon-(1-carboxyethyl) lysine-modified albumin. Biochem J 2002 364 : 1 14.
52. Berlanga J, Cibrian D, Guillen I, Freyre F, Alba JS, Lopez-Saura P, et al. Methylglyoxal administration induces diabetes-like microvascular changes and perturbs the healing process of cutaneous wounds. Clin Sci (Lond) 2005 109 : 83 95.
53. Morita K, Urabe K, Moroi Y, Koga T, Nagai R, Horiuchi S, et al. Migration of keratinocytes is impaired on glycated collagen I. Wound Repair Regen 2005 13 : 93 101.
54. Chong SA, Lee W, Arora PD, Laschinger C, Young EW, Simmons CA, et al. Methylglyoxal inhibits the binding step of collagen phagocytosis. J Biol Chem 2007 282 : 8510 20.
55. Sakata N, Sasatomi Y, Meng J, Ando S, Uesugi N, Takebayashi S, et al. Possible involvement of altered RGD sequence in reduced adhesive and spreading activities of advanced glycation end product-modified fibronectin to vascular smooth muscle cells. Connect Tissue Res 2000 41 : 213 28.